Related Experiment Video
Updated: Jul 25, 2026

Isolation of Murine Lymph Node Stromal Cells
Published on: August 19, 2014
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
E Jensen-Jarolim1,2, H J Bax3,4, R Bianchini1
1The Interuniversity Messerli Research Institute, University of Veterinary Medicine Vienna, Medical University Vienna, University Vienna, Vienna, Austria.
Abstract:
While desired for the cure of allergy, regulatory immune cell subsets and nonclassical Th2-biased inflammatory mediators in the tumour microenvironment can contribute to immune suppression and escape of tumours from immunological detection and clearance. A key aim in the cancer field is therefore to design interventions that can break immunological tolerance and halt cancer progression, whereas on the contrary allergen immunotherapy exactly aims to induce tolerance. In this position paper, we review insights on immune tolerance derived from allergy and from cancer inflammation, focusing on what is known about the roles of key immune cells and mediators. We propose that research in the field of AllergoOncology that aims to delineate these immunological mechanisms with juxtaposed clinical consequences in allergy and cancer may point to novel avenues for therapeutic interventions that stand to benefit both disciplines.
Insights
AllergoOncology research explores immune tolerance in allergy and cancer. Understanding these shared mechanisms may reveal new therapies benefiting both fields.
Area of Science:
- Immunology
- Oncology
- Allergy Research
Background:
- Tumor microenvironments often feature immune suppressive cells and mediators, aiding cancer immune escape.
- Allergen immunotherapy aims to induce tolerance, contrasting with cancer research's goal to break tolerance.
Purpose of the Study:
- To review immune tolerance insights from allergy and cancer inflammation.
- To focus on the roles of key immune cells and mediators in both contexts.
- To propose AllergoOncology as a field to bridge these disciplines.
Main Methods:
- Literature review of immunological mechanisms in allergy and cancer.
- Analysis of immune cells and inflammatory mediators.
- Juxtaposition of clinical consequences in allergy and cancer.
Main Results:
- Regulatory immune cells and Th2 mediators in tumors can cause immune suppression and tumor escape.
- Insights from allergy and cancer highlight contrasting roles of immune tolerance.
- Shared immunological mechanisms exist between allergy and cancer.
Conclusions:
- Delineating shared mechanisms in AllergoOncology can identify novel therapeutic strategies.
- Therapeutic interventions may benefit both allergy and cancer treatment.
- Understanding immune tolerance is crucial for advancing both fields.
Related Concept Videos
Cross-reactivity
Allergic Reactions
Allergic Drug Reactions
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Tumor Immunotherapy

